← All trials
NCT04794803
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 5, 2020
- Primary completion
- Nov 30, 2020
- Completion date
- Feb 2, 2021
- First posted
- Mar 12, 2021
- Last posted
- Mar 16, 2021
- Enrollment
- 55
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Dompe PharmaceuticalsLead sponsor
- Vita-Salute University of Milano. ItalyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.